Concepts (124)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Endocrinology | 39 | 2023 | 139 | 16.650 |
Why?
|
| Diabetes Mellitus | 37 | 2023 | 1054 | 10.270 |
Why?
|
| Standard of Care | 40 | 2023 | 243 | 4.440 |
Why?
|
| Reference Standards | 37 | 2023 | 339 | 4.420 |
Why?
|
| Societies, Medical | 37 | 2023 | 1335 | 3.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 18 | 2023 | 830 | 3.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 9 | 2023 | 1362 | 1.840 |
Why?
|
| Transition to Adult Care | 4 | 2016 | 97 | 1.420 |
Why?
|
| Renal Insufficiency, Chronic | 3 | 2023 | 787 | 1.020 |
Why?
|
| Retinal Diseases | 2 | 2023 | 179 | 0.880 |
Why?
|
| Cardiovascular Diseases | 3 | 2023 | 2195 | 0.750 |
Why?
|
| Insulin | 5 | 2022 | 1454 | 0.730 |
Why?
|
| Hypoglycemic Agents | 8 | 2023 | 586 | 0.680 |
Why?
|
| Prescription Drugs | 1 | 2020 | 64 | 0.680 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2018 | 22 | 0.660 |
Why?
|
| Hyperglycemia | 1 | 2020 | 333 | 0.590 |
Why?
|
| Blood Glucose | 6 | 2022 | 1244 | 0.570 |
Why?
|
| Dyslipidemias | 1 | 2018 | 235 | 0.530 |
Why?
|
| Humans | 60 | 2023 | 261506 | 0.530 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2020 | 598 | 0.500 |
Why?
|
| Adolescent Development | 1 | 2013 | 34 | 0.460 |
Why?
|
| Comorbidity | 6 | 2023 | 2352 | 0.400 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 849 | 0.370 |
Why?
|
| Diabetic Ketoacidosis | 2 | 2021 | 136 | 0.350 |
Why?
|
| Attitude of Health Personnel | 1 | 2015 | 918 | 0.330 |
Why?
|
| Clinical Competence | 1 | 2015 | 1270 | 0.300 |
Why?
|
| Physicians | 1 | 2015 | 882 | 0.290 |
Why?
|
| Insulin Infusion Systems | 3 | 2020 | 53 | 0.260 |
Why?
|
| Blood Glucose Self-Monitoring | 3 | 2020 | 108 | 0.250 |
Why?
|
| Adolescent | 13 | 2023 | 31252 | 0.240 |
Why?
|
| Liraglutide | 1 | 2022 | 16 | 0.220 |
Why?
|
| Islets of Langerhans | 1 | 2023 | 229 | 0.210 |
Why?
|
| Glucagon-Like Peptide-1 Receptor | 1 | 2022 | 60 | 0.210 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2022 | 67 | 0.210 |
Why?
|
| Autoantibodies | 2 | 2023 | 576 | 0.210 |
Why?
|
| Child | 11 | 2023 | 29154 | 0.210 |
Why?
|
| Hospitals | 2 | 2023 | 485 | 0.200 |
Why?
|
| Quality Improvement | 3 | 2023 | 851 | 0.190 |
Why?
|
| Cross-Sectional Studies | 6 | 2021 | 4314 | 0.190 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2023 | 393 | 0.170 |
Why?
|
| Diabetes Complications | 1 | 2020 | 305 | 0.160 |
Why?
|
| Passeriformes | 1 | 2008 | 3 | 0.160 |
Why?
|
| Spatial Behavior | 1 | 2008 | 20 | 0.160 |
Why?
|
| Reproductive Health | 1 | 2018 | 46 | 0.160 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2023 | 421 | 0.160 |
Why?
|
| Health Status Disparities | 1 | 2021 | 291 | 0.160 |
Why?
|
| Exploratory Behavior | 1 | 2008 | 106 | 0.160 |
Why?
|
| Pregnancy | 4 | 2023 | 7573 | 0.140 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 390 | 0.140 |
Why?
|
| Health Education | 1 | 2018 | 309 | 0.140 |
Why?
|
| Young Adult | 7 | 2021 | 21445 | 0.140 |
Why?
|
| Pediatrics | 2 | 2014 | 1141 | 0.130 |
Why?
|
| Adrenal Hyperplasia, Congenital | 1 | 2014 | 45 | 0.120 |
Why?
|
| Behavior, Animal | 1 | 2008 | 709 | 0.120 |
Why?
|
| Physicians, Primary Care | 1 | 2015 | 98 | 0.120 |
Why?
|
| Psychology, Adolescent | 1 | 2013 | 41 | 0.120 |
Why?
|
| Puberty | 1 | 2013 | 104 | 0.110 |
Why?
|
| Drug Therapy, Combination | 1 | 2018 | 2315 | 0.110 |
Why?
|
| Obesity | 2 | 2023 | 2884 | 0.110 |
Why?
|
| Hospitalization | 1 | 2021 | 2083 | 0.100 |
Why?
|
| Patient Care Planning | 1 | 2013 | 297 | 0.100 |
Why?
|
| Adolescent Behavior | 1 | 2013 | 230 | 0.100 |
Why?
|
| Hypertension | 1 | 2020 | 1503 | 0.100 |
Why?
|
| Social Support | 1 | 2013 | 560 | 0.090 |
Why?
|
| Female | 11 | 2023 | 141928 | 0.090 |
Why?
|
| United States | 4 | 2021 | 15433 | 0.090 |
Why?
|
| Adult | 9 | 2023 | 77950 | 0.090 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 748 | 0.080 |
Why?
|
| Primary Health Care | 1 | 2013 | 787 | 0.080 |
Why?
|
| Precision Medicine | 1 | 2013 | 1154 | 0.070 |
Why?
|
| Learning | 2 | 2020 | 403 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 2403 | 0.060 |
Why?
|
| Zinc Transporter 8 | 1 | 2023 | 8 | 0.060 |
Why?
|
| Glutamate Decarboxylase | 1 | 2023 | 44 | 0.060 |
Why?
|
| Registries | 2 | 2021 | 2170 | 0.060 |
Why?
|
| Sodium-Glucose Transporter 2 | 1 | 2021 | 15 | 0.050 |
Why?
|
| Benchmarking | 1 | 2023 | 273 | 0.050 |
Why?
|
| Off-Label Use | 1 | 2021 | 46 | 0.050 |
Why?
|
| Hemoglobin, Sickle | 1 | 2021 | 25 | 0.050 |
Why?
|
| Male | 6 | 2021 | 123000 | 0.050 |
Why?
|
| Parity | 1 | 2020 | 139 | 0.050 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2020 | 51 | 0.050 |
Why?
|
| Age Factors | 2 | 2021 | 5377 | 0.050 |
Why?
|
| Sodium | 1 | 2021 | 353 | 0.050 |
Why?
|
| Child, Preschool | 3 | 2021 | 16273 | 0.040 |
Why?
|
| Pregnant Women | 1 | 2020 | 162 | 0.040 |
Why?
|
| Aged | 2 | 2023 | 70117 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2020 | 341 | 0.040 |
Why?
|
| Health Behavior | 1 | 2023 | 603 | 0.040 |
Why?
|
| Biomarkers | 2 | 2021 | 5047 | 0.040 |
Why?
|
| Patient Care Team | 1 | 2023 | 795 | 0.040 |
Why?
|
| Age of Onset | 1 | 2020 | 827 | 0.040 |
Why?
|
| Orientation | 1 | 2008 | 57 | 0.040 |
Why?
|
| Space Perception | 1 | 2008 | 77 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2020 | 362 | 0.040 |
Why?
|
| Triglycerides | 1 | 2020 | 603 | 0.040 |
Why?
|
| Socioeconomic Factors | 1 | 2021 | 1225 | 0.040 |
Why?
|
| Treatment Outcome | 2 | 2018 | 32848 | 0.040 |
Why?
|
| Cues | 1 | 2008 | 192 | 0.040 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 941 | 0.040 |
Why?
|
| Cholesterol, LDL | 1 | 2020 | 565 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2023 | 929 | 0.030 |
Why?
|
| Glucose | 1 | 2021 | 1248 | 0.030 |
Why?
|
| Self Care | 1 | 2016 | 224 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 860 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2021 | 2450 | 0.030 |
Why?
|
| Counseling | 1 | 2016 | 381 | 0.030 |
Why?
|
| Risk Factors | 2 | 2021 | 17523 | 0.030 |
Why?
|
| Liver | 1 | 2023 | 2961 | 0.030 |
Why?
|
| Prevalence | 1 | 2021 | 3260 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2018 | 2803 | 0.030 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2018 | 1209 | 0.020 |
Why?
|
| Disease Progression | 1 | 2021 | 6682 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 4892 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 1085 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2021 | 6869 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2021 | 8223 | 0.020 |
Why?
|
| Texas | 1 | 2018 | 6311 | 0.020 |
Why?
|
| Quality of Life | 1 | 2021 | 4532 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2018 | 5687 | 0.020 |
Why?
|
| Infant | 1 | 2021 | 13310 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 12926 | 0.020 |
Why?
|
| Prognosis | 1 | 2021 | 21713 | 0.010 |
Why?
|
| Animals | 1 | 2008 | 59536 | 0.010 |
Why?
|